Ignite Creation Date:
2024-05-06 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05344690
Status:
COMPLETED
Last Update Posted:
2024-02-07
First Post:
2022-04-19
Brief Title:
SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Evaluation of the Relationship Between SLMAP and EPO Genetic Polymorphism and the Risk of Diabetic Retinopathy in Egyptian Diabetic Patients A Case-Control Study
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A case-control study to assess the association between the risk of diabetic retinopathy in Egyptians and genetic polymorphism of both EPO and SLMAP genes
Detailed Description:
Traditional environmental risk factors such as glycemic control and duration of diabetes failed to fully explain why some individuals remain protected while others progress to severe diabetic retinopathy
Several studies suggest variations in diabetic retinopathy prevalence depending on racial background and genetic polymorphism
Several studies suggest variations in diabetic retinopathy prevalence depending on racial background and genetic polymorphism
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None